C

RTW Biotech Opportunities Ltd RTWFF

$2.45 $0.010.41% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

RTW Biotech Opportunities Ltd is a closed-ended investment company focused on the biotechnology and life sciences sectors. The company’s core activity is investing in publicly traded and private biotech companies developing novel therapeutics, platform technologies, and life science innovations. It operates within the healthcare investment and biotechnology finance industries, providing capital to companies across various stages of clinical development.

The company’s primary revenue driver is capital appreciation from its investment portfolio, supplemented by gains from private-to-public transitions and selective exits. RTW Biotech Opportunities Ltd primarily serves institutional and sophisticated investors seeking exposure to biotechnology innovation through an actively managed structure. Its strategic advantage lies in being externally managed by RTW Investments, a specialist life sciences investment firm with deep scientific, clinical, and regulatory expertise. The company was incorporated in 2019 and launched following its initial public offering on the London Stock Exchange, positioning itself as a long-term capital provider to the global biotech ecosystem.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, September 14, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
End of March (est)

Price History

Loading...
52-Week Range79% of range
Low
$1.56
Current
$2.45
High
$2.68
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
646 597 6980
Address
40 10th Avenue
Seventh Floor
New York, NY 10014
Country
Year Founded

Headlines

There are no news to display.